Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial

Patrick G. Kehoe, Bernadette McGuinness, Beth Howden et al.|The Lancet Neurology|2021

Cited by 59